ABHD11-AS1 Gene

Name ABHD11 antisense RNA 1 (tail to tail)
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA ABHD11‐AS1 is emerging as an important oncogenic regulator that is frequently upregulated in a variety of human cancers and is associated with aggressive clinicopathological features and poor patient prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": " In papillary thyroid carcinoma, ABHD11‐AS1 has been shown to promote cell proliferation and metastasis by enhancing PI3K/AKT signaling and acting as a competing endogenous RNA (ceRNA) that sponges microRNAs such as miR‑1301‑3p to upregulate factors like STAT3."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In digestive tumors, its elevated levels in gastric tissues and even gastric juice support its utility as a minimally invasive biomarker, while in colorectal cancer ABHD11‐AS1 contributes to tumor progression by sponging microRNAs (for example, miR‑1254 and miR‑133a) that normally suppress pro‐oncogenic targets such as WNT11 and SOX4."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Similarly, in gastric cancer, it modulates the miR‑361‑3p/PDPK1 axis, and in cervical cancer it sequesters miR‑330‑5p to upregulate MARK2, thereby facilitating cell migration and epithelial–mesenchymal transition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In pancreatic cancer, ABHD11‐AS1 has been implicated in the regulation of cyclin E1 and in the activation of the PI3K/AKT pathway to enhance cell proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Moreover, its oncogenic role is evident in other malignancies such as ovarian, bladder, and endometrial cancers, where it modulates key molecules – for instance, by interacting with EZH2 to silence tumor suppressors (e.g. TIMP2) in ovarian cancer, or by binding cyclin D1 to drive cell cycle progression in endometrial carcinoma."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "13"}]}, {"type": "t", "text": " Overall, these studies, along with recent reviews summarizing its multifaceted roles across tumor types"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", highlight ABHD11‐AS1 as a promising candidate for diagnostic biomarker development and therapeutic targeting in cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xi Zhuang, Houchao Tong, Yu Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1850-4"}], "href": "https://doi.org/10.1038/s41419-019-1850-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31409775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31409775"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Juyi Wen, Hongwei Wang, Tingjun Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.12569"}], "href": "https://doi.org/10.1111/cpr.12569"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30657221"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30657221"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yunben Yang, Yongfu Shao, Mengying Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3903-3"}], "href": "https://doi.org/10.1007/s13277-015-3903-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26280398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26280398"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Dedong He, Zhongyi Yue, Lingling Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.27877"}], "href": "https://doi.org/10.1002/jcp.27877"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30537177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30537177"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiaoyan Lei, Longchao Li, Xiaoyi Duan "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181386"}], "href": "https://doi.org/10.1042/BSR20181386"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30429229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30429229"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hairong Xin, Zhifeng Yan, Jie Cao "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 boosts gastric cancer development by regulating miR-361-3p/PDPK1 signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvaa065"}], "href": "https://doi.org/10.1093/jb/mvaa065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32678870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32678870"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Shunyu Hou, Xiaoqian Zhang, Jian Yang "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2021.112929"}], "href": "https://doi.org/10.1016/j.yexcr.2021.112929"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34793775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34793775"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bowei Liu, Wei Wang, Suofeng Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Onco Targets Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/OTT.S259598"}], "href": "https://doi.org/10.2147/OTT.S259598"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33177842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33177842"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "X Qiao, S-X Lv, Y Qiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201812_16627"}], "href": "https://doi.org/10.26355/eurrev_201812_16627"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30575903"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30575903"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "H Lu, C Zhu, Y Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Transl Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12094-021-02753-z"}], "href": "https://doi.org/10.1007/s12094-021-02753-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35098448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35098448"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xiang-Yang Zeng, Xiao-Yan Jiang, Jia-Hui Yong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2586"}], "href": "https://doi.org/10.1002/cam4.2586"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31568657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31568657"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mingwei Chen, Jianfa Li, Chengle Zhuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14945"}], "href": "https://doi.org/10.18632/oncotarget.14945"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28157695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28157695"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yao Liu, Li-Li Wang, Shuo Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13675"}], "href": "https://doi.org/10.1111/jcmm.13675"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29799152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29799152"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Upendarrao Golla, Kishore Sesham, Siva Dallavalasa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Noncoding RNA (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ncrna8020021"}], "href": "https://doi.org/10.3390/ncrna8020021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35314614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35314614"}]}]}]}
Synonyms LINC00035, NCRNA00035, WBSCR26
NCBI Gene ID 171022
API
Download Associations
Predicted Functions View ABHD11-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View ABHD11-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View ABHD11-AS1's ARCHS4 Predicted Functions.

Functional Associations

ABHD11-AS1 has 1,452 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.

Click the + buttons to view associations for ABHD11-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of ABHD11-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of ABHD11-AS1 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of ABHD11-AS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at ABHD11-AS1 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of ABHD11-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of ABHD11-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of ABHD11-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ABHD11-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of ABHD11-AS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of ABHD11-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of ABHD11-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at ABHD11-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of ABHD11-AS1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.